Ombitasvir/paritaprevir/ritonavir+dasabuvir and ribavirin associated drug-induced liver injury and syndrome of inappropriate secretion of anti-diuretic hormone: A case report

Clin Mol Hepatol. 2019 Sep;25(3):326-330. doi: 10.3350/cmh.2018.0063. Epub 2018 Dec 4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • 2-Naphthylamine
  • Anilides / therapeutic use
  • Anilides / toxicity
  • Antiviral Agents / therapeutic use
  • Antiviral Agents / toxicity*
  • Carbamates / therapeutic use
  • Carbamates / toxicity
  • Chemical and Drug Induced Liver Injury / diagnosis*
  • Creatinine / blood
  • Cyclopropanes
  • Drug Therapy, Combination
  • Genotype
  • Hepacivirus / genetics
  • Hepacivirus / isolation & purification
  • Hepatitis C / drug therapy
  • Humans
  • Lactams, Macrocyclic
  • Liver Function Tests
  • Macrocyclic Compounds / therapeutic use
  • Macrocyclic Compounds / toxicity
  • Male
  • Middle Aged
  • Proline / analogs & derivatives
  • Ribavirin / therapeutic use
  • Ribavirin / toxicity
  • Ritonavir / therapeutic use
  • Ritonavir / toxicity
  • Sodium / blood
  • Sulfonamides / therapeutic use
  • Sulfonamides / toxicity
  • Uracil / analogs & derivatives
  • Uracil / therapeutic use
  • Uracil / toxicity
  • Valine

Substances

  • Anilides
  • Antiviral Agents
  • Carbamates
  • Cyclopropanes
  • Lactams, Macrocyclic
  • Macrocyclic Compounds
  • Sulfonamides
  • ombitasvir
  • Ribavirin
  • Uracil
  • Proline
  • Sodium
  • Creatinine
  • 2-Naphthylamine
  • dasabuvir
  • Valine
  • Ritonavir
  • paritaprevir